FDA Approves Unknown Drug — NOVARTIS
Regulatory approval was granted by the FDA on April 20, 2010, for the drug developed by Novartis under NDA021560; this clearance is anticipated to bolster the company's commercial portfolio and provide a significant financial upside.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed